Targeting BRCA2 deficiency with GSK3 inhibitors
<p>BRCA1 and BRCA2 tumour suppressors are essential for homologous recombination-mediated double-strand break repair and replication fork protection. Therefore, BRCA1 and BRCA2 are essential for cell viability. Deactivating mutations in one of these genes lead to genome instability and are ass...
מחבר ראשי: | Zonderland, G |
---|---|
מחברים אחרים: | Tarsounas, M |
פורמט: | Thesis |
יצא לאור: |
2017
|
פריטים דומים
-
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
מאת: Tacconi, E, et al.
יצא לאור: (2019) -
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
מאת: Eliana MC Tacconi, et al.
יצא לאור: (2019-05-01) -
Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds
מאת: Zimmer, J, et al.
יצא לאור: (2016) -
Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights
מאת: Ashwin Ragupathi, et al.
יצא לאור: (2023-03-01) -
Novel approaches for targeting BRCA2-deficient tumour cells
מאת: Tacconi, E
יצא לאור: (2015)